Skip to content
Research Article Open access CC BY 4.0

Congenital Deficiency in Factor VII Revealed by Menorrhagia: Case Report

Nadia Mebrouk, Abdelilah Radi, Mohamed Selouti, Amal Hassani, Abdelhakim Ourrai, Mohamed Kmari, Rachid Abilkassem, Aomar Agadr

Asian Journal of Pediatric Research · pp. 1–5 · Published 22 Jul 2020

10.9734/ajpr/2020/v4i130138

Abstract

Factor VII (FVII) deficiency is the most common among rare inherited autosomal recessive bleeding disorders. It is a multifaceted disease because of the lack of a direct correlation between plasma levels of coagulation FVII and bleeding manifestations. Clinical phenotypes range from asymptomatic condition—even in homozygous subjects—to severe, life-threatening bleedings (e.g., central nervous system and gastrointestinal bleeding). Menorrhagia is a frequent type of bleeding in FVII deficiency, with a prevalence rate of two in three women aged 10 to 50 years and with a peak prevalence in teenagers. When menorrhagia is observed and once the gynecological causes are excluded, it is important to carry out a hemostasis assessment because, if an anomaly is found, specific treatment can be administered and preventive measures taken. Basic diagnostic work-up includes routine assays, prothrombin level, activated partial thromboplastin time and platelet count, followed by FVII coagulant activity measurement for isolated decreased prothrombin level. To confirm the diagnosis, FVII assay should be repeated at least once. Several treatment options are currently available for FVII deficiency: Recombinant activated Factor VII (rFVIIa), plasma-derived Factor VII, fresh frozen plasma and prothrombin complex concentrates. rFVIIa is the most used replacement therapy. Other medical therapies of menorrhagia includes hemostatic agents and hormonal treatments (combined oral contraceptives, levonorgestrel intrauterine devices), in combination or not with rFVIIa. We report the case of a fourteen-and-a-half-year-old girl who presented menorrhagia of great abundance at the age of thirteen, the exploration of which revealed a congenital deficit in FVII.

Factor VII congenital deficiency menorrhagia recombinant activated factor VII.

References (12)

  1. 1 “Normal” Thrombin Generation [DOI]
  2. 2 Clinical phenotypes and factor VII genotype in congenital factor VII deficiency [DOI]
  3. 3 Factor VII Deficiency: Clinical Phenotype, Genotype and Therapy [DOI]
  4. 4 The Tissue Factor Pathway: How It Has Become a “Prima Ballerina” [DOI]
  5. 5 Congenital factor VII deficiency: therapy with recombinant activated factor VII – a critical appraisal [DOI]
  6. 6 Analysis of biological phenotypes from 42 patients with inherited factor VII deficiency: can biological tests predict the bleeding risk?
  7. 7 Iron-dependent erythropoiesis in women with excessive menstrual blood losses and women with normal menses [DOI]
  8. 8 Women with congenital factor VII deficiency: clinical phenotype and treatment options from two international studies [DOI]
  9. 9 Factor VII deficiency – an enigma; clinicohematological profile in 12 cases [DOI]
  10. 10 Pharmacokinetic properties of recombinant FVIIa in inherited FVII deficiency account for a large volume of distribution at steady state and a prolonged pharmacodynamic effect [DOI]
  11. 11 Treatment of Factor VII Deficiency with Recombinant Factor VIla [DOI]
  12. 12 Déficit congénital en facteur VII : à propos d’une observation [DOI]

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

42

Page views

0

PDF downloads

4

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.